AstraZeneca’s board rejects Pfizer’s takeover offer
MLex Summary: AstraZeneca’s board rejected Pfizer’s revised takeover offer, saying it “substantially” undervalues the company.Full statement below:...To view the full article, register now.
Already a subscriber? Click here to view full article